期刊文献+

母细胞性浆细胞样树突细胞肿瘤 被引量:2

Blastic plasmacytoid dendritic cell neoplasm
下载PDF
导出
摘要 报告1例母细胞性浆细胞样树突细胞肿瘤。患者女,26岁。面部结节、斑块半年。皮肤科检查:右颧部可见约4 cm×6 cm暗红色浸润性斑块,类圆形分叶状,境界清楚,皮损中央破溃。皮损组织病理检查:真皮全层及皮下脂肪间见较多致密的异形淋巴细胞浸润,细胞中等大小,核膜薄,染色质细,核分裂象易见。免疫组化:CD4(+)、CD56(+)、CD123(+)、CD43(+)、CD34(+),Ki-67(>60%阳性);CD20、CD79a、丝氨酸蛋白酶(granzyme)B、CD3、CD45RO、CD68、末端脱氧核苷酸转移酶(TDT)、髓过氧化物酶(MPO)、T细胞内抗原(TIA)-1均阴性。诊断:母细胞性浆细胞样树突细胞肿瘤。 A case of blastic plasmacytoid dendritic cell neoplasm (BPDCN) is reported. A 26-year-old female presented with nodule and plaque on the face for 6 months. Physical examination revealed a demarcated, dark erythematous and infiltrated plaque, sized 4cm × 6 cm in diameter, on the right cheek. Histopathological examination showed diffuse infiltrate of numerous medium-sized atypical lymphocytes with irregular nuclei in superficial dermis and subcutaneous fat tissue. The biastic cells showed fine-granular chromatin and abundant mitotic figures. Immunohistoehemical staining showed that tumor cells were positive for CD4, CD56,CD123,CD34 and CD43, but negative for CD3, CD45RO, CD68, TDT, CD20, CD79A, granzyme B, TIA-1 and MPO. The diagnosis of BPDCN was made.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2015年第5期306-308,共3页 Journal of Clinical Dermatology
关键词 母细胞性浆细胞样树突细胞肿瘤 干细胞 blastic plasmacytoid dendritic cell neoplasm stem cells
  • 相关文献

参考文献12

  • 1Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N -CAM)in a patient with cutaneous CD4 -positive lymphoma[J]. Am J Hematol, 1994, 47(4): 278-282.
  • 2Swerdlow SH. Campo E, Harris NL, et al. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues [M]. Lyon, France:1ARC Press, 2008: 145-147.
  • 3Wiesner T, Obenauf AC, Cota C, el al. Alterations of the cell-cycle inhibitors p27(K1P1)and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms[J]. J Invest Dermatol, 2010, 130(4): 1152-1157.
  • 4Petrella T, Dalac S, Maynadie M, et al. CD4+CD56+cutaneous neoplasms: a distinct hematological entity? Groupe Franqais d' E tude des Lymphomes Cutanes (GFELC) [J]. Am J Surg Pathol, 1999, 23(2): 137-146.
  • 5Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+/CD56+hematodennic neoplasms): a review [J]. Am JOlin Pathol, 2005, 123(5): 662-675.
  • 6Herhng M, Jones D. CD4+/CD56+hematodennic tumor.the features of an evolving entity and its relationship to dendritic cells [J]. Am JOlin Pathol, 2007, 127(5): 687-700.
  • 7Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications [J]. Haematologica, 2010, 95 (11): 1873 - 1879.
  • 8Shiman M, Marchione R, Ricotti C, el al. CD4+/CD56+Hematodermic neoplasm(plasmacytoid dendritic cell tumor)[J]. Dennatol Online J, 2008, 14(11): 5.
  • 9Pina-Oviedo S, Herrera-Medina H, Coronado H, et al. CD4+/ CD56+hematodennic neoplasm: presentation of 2 cases and review of the concept of all uncommon tumour originated in plasmacytoid dendritic cells expressing CDl23 (IL-3 receptor alpha) [J]. Appl lmmunohistochem Mol Morphol, 2007, 15(4): 481-486.
  • 10Bekkenk MW, Jansen PM, Meijer CJ, el al. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature[J]. Ann One- 01, 2004, 15(7): 1097-1108.

二级参考文献17

  • 1Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC, 2008: 145-155.
  • 2Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CDg-positive lymphoma. Am J Hematol, 1994, 47(4): 278-252.
  • 3Borchiellini D, Ghibaudo N, Mounier N, et al. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature [J/OL]. J Eur Acad Dermatol Venereol. [2012-08-15]. http://onlinelibrary.wiley.com/doi/10.11 ll/j. 1468-3083.2012.04503.x [published online ahead of print Mar 27, 2012]. doi: lO.1111/j.1468-3083.2012.04503.x.
  • 4Jaffe ES, Harris NL, Stein H, et al. Wond Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. 3th ed. Lyon: IARC, 2001: 214-215.
  • 5Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood, 2001, 97(10): 3210-3217.
  • 6Jaye DL, Geigerman CM, Herling M, et al. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4 * CD56 hematodermic neoplasms. Mod Pathol, 2006, 19(12): 1555-1562. P.
  • 7ilichowska ME, Fleming MD, Pinkus JL, et al. CD4/CD56 hematodermic neoplasm ( "blastic natural killer cell lymphoma" ): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon. Am J Clin Pathol, 2007, 128(3 ): 445-453.
  • 8Giagounidis AA, Heinsch M, Haase S, et al. Early plasmacytoid dendritic cell leukemia/lymphoma coexpressing myeloid antigenes. Ann Hematol, 2004, 83(11): 716-721.
  • 9Inoue D, Maruyama K, Aoki K, et al. Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen. Acta Haematol, 2011, 126(2): 122-128.
  • 10Dalle S, Beylot-Barry M, Bagot M, et al. Blastic plasmaeytoid dendritic cell neoplasm: is transplantation the treatment of choice?. Br J Dermatol, 2010, 162(1 ): 74-79.

共引文献15

同被引文献13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部